Logos Capital: A fundamental investment fund specializing in biotechnology.
Location
San Francisco, CA, US
Founded
2019
Logos Capital is a fundamental biotechnology-focused investment partnership based in San Francisco. The firm specializes in identifying transformative therapies in healthcare by combining scientific and financial expertise with in-house clinical trial analytics. Logos Capital's investment focus spans various stages, with a particular emphasis on Series A, B, and C rounds in the biotechnology sector.
The firm's portfolio includes notable companies such as Freenome, Synthego, and Element Biosciences. Logos Capital's investment philosophy is rooted in seeking empirical truth and rigorous scientific diligence, as reflected in their name, which means "logic and discourse" in Greek. Their unique value proposition lies in their interdisciplinary approach, combining expertise across medical, scientific, and statistical disciplines to make informed investment decisions.
Logos Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
